| Methods | Prospective, randomized controlled trial conducted in Turkey |
| Participants | Inclusion Criteria: preterm infants with a gestational age ≤32 week and a birth weight ≤ 1500 g |
| Exclusion Crietria: "detected chromosomal abnormalities, previous gastrointestinal system surgery, a diagnosis of metabolic disease, babies lost in the first postnatal week and babies with severe sepsis episode were excluded from the study" | |
| Interventions | Intervention: Probiotic supplementation: Lactobacillus rhamnosus (4.1×108 cfu) + Lactobacillus casei (8.2×108 cfu) + Lactobacillus plantorum (4.1×108 cfu) + Bifidobacterium animalis (4.1×108 cfu) |
| Comparison: No probiotics | |
| Outcomes | Mortality, NEC, sepsis |
| Notes | Data were taken from table 2 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.